Contact us
menu

Disease Management Platform

Empower patients with a proactive and holistic digital health platform to enhance their treatment journey and improve their overall wellbeing.

Empower Your Patients By Transforming Their Chronic Disease Management

A Disease Management Platform is a proactive, comprehensive approach that aims to improve the quality of life of patients with chronic diseases, while seeking to reduce healthcare costs.
It involves coordinated interventions and communications between different stakeholders for chronic diseases where self-management efforts can play an important role. By leveraging a comprehensive digital platform, patients can easily track the progress of their disease, communicate better with their healthcare team and live an enhanced treatment experience.

Discover Aptar Digital Health Respiratory Disease Management Platform

Theย Aptar Digital Healthย  Respiratory Disease Management Platformย is designed to improve asthma symptom control, technique and engagement. It includes a patient mobile application that connects to inhaler sensors, such as Aptar Digital Healthโ€™s HeroTrackerยฎ Sense, and a software portal for healthcare professionals. It aims to empower individuals by offering medication and symptoms management with real-time tracking, reminders and educational resources via a mobile app. By fostering behavior change and facilitating adherence, this digital platform aims to reduce asthma symptoms, rescue medication usage, exacerbations and unnecessary healthcare visits.

Transforming the Management of Chronic Disease

Disease Management Platform offers valuable insights through advanced analytics, enabling data-driven decision-making and optimized resource allocation. By fostering collaboration among patients, providers, clinical centers and payers, we aim to generate evidence to create a more efficient and effective healthcare ecosystem. Focus on respiratory diseases, Aptar Digital Health’s Disease Management Platform is composed of:

Impacting Adult Asthma Management

ADHERENCE
45%

Controller medication adherence was 45% higher than the US asthma medication average

ASTHMA CONTROL
19.3%

ACT scores indicated well controlled asthma after 90 days (16.5 vs. 19.3)

RESCUE MEDICATION
44%

Rescue medication use decreased by 44% after 90 days

Aptar Digital Health conducted an observational study on 104 adult asthma patients in the U.S using Aptar Digital Healthโ€™s Respiratory Disease Management Platform. For 90 days, patients were able to track their lung function, medication adherence and received medical reminders and tailored education content.

Read the Scientific Poster

Disease Management Platform’s Features

Disease management platforms offer multiple benefits for pharmaceutical companies. These solutions empower patients by providing personalized care, reminders, and educational resources. By collecting and analyzing patient data, pharma companies gain valuable insights into treatment efficacy and patient outcomes, informing future drug development and marketing strategies.

Embrace the digital health transformation and stay competitive in the evolving healthcare landscape with a robust Disease Management Platform.

Connected devices integration

Inhalation devices such as FENO device, Spriometer (Peak Expiratory Flow FEV1, FVC, FEV6), AI with voice technology capabilities and any drg delivery system needed to be used by the patient to properly take their medication (pump, pen, auto-injector)

Medication tracking

Log each time you take your medication to keep track of your adherence. This can help you and your healthcare provider monitor your treatment and assess your adherence.

Educational content

Access reliable, trustable and updated resources, videos and articles to better manage your daily life.

Health trends

Analyze trends and share health reports with your healthcare team.

Symptoms monitoring

Report your symptoms in the app to assess them and take direct action to control them.

Physical activity

Track your daily step count and active minutes

A patient using his phone for onboard a new treatment

Strategic Partnership with Chiesi

 

Chiesi and Aptar Digital Health partnered in 2022 to leverage Aptar Digital Health’s Respiratory Disease Management Platform that is designed to empower patients, provide healthcare professionals with data-driven insights to better manage their patients and build evidence for reimbursement in the field of digital health for asthma and COPD. The platform offers a comprehensive set of services and solutions aimed at bringing together both the pharmacological and behavioral aspects of managing respiratory diseases, such asย  adherence monitoring, lung function assessment, reporting symptoms, identifying disease triggers and communication with care teams and health coaches.

Read the announcement

Clinical Study in the U.K

Guys st Thomas' hospital logo and ADH's

Guyโ€™s and St Thomasโ€™ NHS Foundation Trust, a leading Trust in London in the United Kingdom, launched a clinical study to evaluate the impact of Aptar Digital Healthโ€™s Respiratory Disease Management Platform on asthma patients.

Find out more

Back to top
Follow us: subscribe